«Back

Company-Led Recall on PACLITAXEL VIAL 150MG Pfizer

Company-Led Recall on PACLITAXEL VIAL 150MG Pfizer

Hospira UK Limited (Pfizer) is recalling the above batch of the Paclitaxel 6 mg/ml concentrate for solution for infusion (150mg/25ml) as a precautionary measure. This is due to a manufacturing issue which could potentially have resulted in a loss of sterility assurance.

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP Code Product Description Supplier Affected Batch
8121204 PACLITAXEL VIAL 150MG PFIZER LTD F016842AD

For stock enquiries, please contact your original supplier or local branch of Alliance Healthcare.

For medical information please contact Pfizer Medical Information Department on 01304 616161

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

Stock should not be consolidated and returns should be sent back to your original supplier. 

The final date for accepting stock back for credit is 18 March 2020. 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

If you have any questions, then please contact your local Service Centre Customer Services team.